Pelage Pharmaceuticals
Pelage Pharmaceuticals is a clinical-stage regenerative medicine company developing novel treatments for hair loss, focusing on androgenetic alopecia and chemotherapy-induced alopecia. Their lead program, PP405, is a topical treatment designed to reactivate dormant hair follicle stem cells to stimulate hair growth. The company is advancing a new class of treatments to restore the body's natural hair growth ability.
Funding Round: Series A1
Funding Amount: $14M
Date: 13-Aug-2024
Investors: GV (Google Ventures), Main Street Advisors, Visionary Ventures, YK BioVentures
Markets: Regenerative Medicine, Biotech, Healthtech, Dermatology, Hair Follicle Regeneration, Therapeutic Innovation, Clinical Trials, Androgenetic Alopecia, Telogen Effluvium, Chemotherapy-induced Hair Loss, Anti-aging
HQ: Los Angeles, California, United States
Founded: 2018
Website: https://pelagepharma.com/
LinkedIn: https://www.linkedin.com/company/pelage-pharmaceuticals
Crunchbase: https://www.crunchbase.com/organization/pelage-pharma
Leave a Comment
Comments
No comments yet.